Spitznagel Thomas's most recent trade in Macrogenics Inc was a trade of 150,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 25,000 | 25,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 13,332 | 0 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 13,332 | 44,063 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. | 12 Feb 2026 | 5,520 | 38,543 (0%) | 0% | 1.7 | 9,439 | Common Stock |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 8,999 | 33,917 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 8,999 | 9,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 6,001 | 11,999 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 6,001 | 27,403 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 07 Feb 2026 | 3,186 | 30,731 (0%) | 0% | 1.8 | 5,767 | Common Stock |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 07 Feb 2026 | 2,485 | 24,918 (0%) | 0% | 1.8 | 4,498 | Common Stock |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 13,332 | 13,332 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 13,332 | 26,922 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 15 Feb 2025 | 5,520 | 21,402 (0%) | 0% | 2.6 | 14,131 | Common Stock |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 18,000 | 18,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 9,001 | 17,999 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 9,001 | 17,317 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 07 Feb 2025 | 3,727 | 13,590 (0%) | 0% | 2.6 | 9,690 | Common Stock |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 10,000 | 77,000 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 04 Mar 2024 | 10,000 | 8,316 (0%) | 0% | 20 | 200,000 | Common Stock |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.50 per share. | 04 Mar 2024 | 10,000 | 18,316 (0%) | 0% | 11.5 | 115,000 | Common Stock |
| Macrogenics Inc | Spitznagel Thomas | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 13,336 | 13,336 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Spitznagel Thomas | Sr VP, Technical Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 13,336 | 26,664 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.40 per share. | 15 Feb 2024 | 5,020 | 8,316 (0%) | 0% | 17.4 | 87,348 | Common Stock |
| Macrogenics Inc | Spitznagel Thomas | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 71,000 | 71,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Spitznagel Thomas | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 27,000 | 27,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 170,000 | 170,000 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 40,000 | 40,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 140,000 | 140,000 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, BPD & Manufacturing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 16 Jul 2021 | 5,000 | 5,000 (0%) | 0% | 7.5 | 37,550 | Common Stock |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, BPD & Manufacturing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2021 | 5,000 | 37,147 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, BPD & Manufacturing | Sale of securities on an exchange or to another person at price $ 25.01 per share. | 16 Jul 2021 | 5,000 | 0 (0%) | 0% | 25.0 | 125,050 | Common Stock |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, BPD & Manufacturing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2021 | 5,000 | 42,147 | - | - | Employee stock option (right to buy) | |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, BPD & Manufacturing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 15 Apr 2021 | 5,000 | 5,000 (0%) | 0% | 7.5 | 37,550 | Common Stock |
| Macrogenics Inc | Thomas Spitznagel | Sr VP, BPD & Manufacturing | Sale of securities on an exchange or to another person at price $ 30.91 per share. | 15 Apr 2021 | 5,000 | 0 (0%) | 0% | 30.9 | 154,550 | Common Stock |